These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 23950967

  • 1. Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study).
    Rubio-Valera M, Bosmans J, Fernández A, Peñarrubia-María M, March M, Travé P, Bellón JA, Serrano-Blanco A.
    PLoS One; 2013; 8(8):e70588. PubMed ID: 23950967
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.
    Bosmans JE, Brook OH, van Hout HP, de Bruijne MC, Nieuwenhuyse H, Bouter LM, Stalman WA, van Tulder MW.
    Pharmacoeconomics; 2007; 25(1):25-37. PubMed ID: 17192116
    [Abstract] [Full Text] [Related]

  • 3. Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol.
    Rubio-Valera M, Serrano-Blanco A, Travé P, Peñarrubia-María MT, Ruiz M, Pujol MM.
    BMC Public Health; 2009 Aug 05; 9():284. PubMed ID: 19656386
    [Abstract] [Full Text] [Related]

  • 4. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
    Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, Sherlock S, Turner N, Button K, Odondi L, Metcalfe C, Owen-Smith A, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G.
    Health Technol Assess; 2014 May 05; 18(31):1-167, vii-viii. PubMed ID: 24824481
    [Abstract] [Full Text] [Related]

  • 5. The Costs and Cost-effectiveness of Collaborative Care for Adolescents With Depression in Primary Care Settings: A Randomized Clinical Trial.
    Wright DR, Haaland WL, Ludman E, McCauley E, Lindenbaum J, Richardson LP.
    JAMA Pediatr; 2016 Nov 01; 170(11):1048-1054. PubMed ID: 27654449
    [Abstract] [Full Text] [Related]

  • 6. Economic evaluation of Internet-based problem-solving guided self-help treatment in comparison with enhanced usual care for depressed outpatients waiting for face-to-face treatment: A randomized controlled trial.
    Kolovos S, Kenter RM, Bosmans JE, Beekman AT, Cuijpers P, Kok RN, van Straten A.
    J Affect Disord; 2016 Aug 01; 200():284-92. PubMed ID: 27155071
    [Abstract] [Full Text] [Related]

  • 7. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.
    Wiles NJ, Thomas L, Turner N, Garfield K, Kounali D, Campbell J, Kessler D, Kuyken W, Lewis G, Morrison J, Williams C, Peters TJ, Hollinghurst S.
    Lancet Psychiatry; 2016 Feb 01; 3(2):137-44. PubMed ID: 26777773
    [Abstract] [Full Text] [Related]

  • 8. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.
    Elliott RA, Tanajewski L, Gkountouras G, Avery AJ, Barber N, Mehta R, Boyd MJ, Latif A, Chuter A, Waring J.
    Pharmacoeconomics; 2017 Dec 01; 35(12):1237-1255. PubMed ID: 28776320
    [Abstract] [Full Text] [Related]

  • 9. One size fits some: the impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention.
    Pyne JM, Rost KM, Farahati F, Tripathi SP, Smith J, Williams DK, Fortney J, Coyne JC.
    Psychol Med; 2005 Jun 01; 35(6):839-54. PubMed ID: 15997604
    [Abstract] [Full Text] [Related]

  • 10. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality) .
    Ont Health Technol Assess Ser; 2021 Jun 01; 21(13):1-214. PubMed ID: 34484487
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study).
    Rubio-Valera M, Peñarrubia-María MT, Iglesias-González M, Knapp M, McCrone P, Roig M, Sabes-Figuera R, Luciano JV, Mendive JM, Murrugara-Centurión AG, Alonso J, Serrano-Blanco A.
    Eur J Health Econ; 2019 Jul 01; 20(5):703-713. PubMed ID: 30725226
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: a randomized controlled superiority trial.
    Rubio-Valera M, March Pujol M, Fernández A, Peñarrubia-María MT, Travé P, López Del Hoyo Y, Serrano-Blanco A.
    Eur Neuropsychopharmacol; 2013 Sep 01; 23(9):1057-66. PubMed ID: 23219937
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE, Hermens ML, de Bruijne MC, van Hout HP, Terluin B, Bouter LM, Stalman WA, van Tulder MW.
    J Affect Disord; 2008 Nov 01; 111(1):106-12. PubMed ID: 18342952
    [Abstract] [Full Text] [Related]

  • 14. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL, Jones MK, Ritter M.
    J Manag Care Pharm; 2008 Nov 01; 14(9):831-43. PubMed ID: 19006440
    [Abstract] [Full Text] [Related]

  • 15. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: A systematic review and meta-analysis.
    Readdean KC, Heuer AJ, Scott Parrott J.
    Res Social Adm Pharm; 2018 Apr 01; 14(4):321-331. PubMed ID: 28622997
    [Abstract] [Full Text] [Related]

  • 16. Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care.
    Eveleigh R, Grutters J, Muskens E, Oude Voshaar R, van Weel C, Speckens A, Lucassen P.
    Fam Pract; 2014 Oct 01; 31(5):578-84. PubMed ID: 25121977
    [Abstract] [Full Text] [Related]

  • 17. A supported self-help for recurrent depression in primary care; An economic evaluation alongside a multi-center randomised controlled trial.
    Biesheuvel-Leliefeld KEM, Bosmans JE, Dijkstra-Kersten SMA, Smit F, Bockting CLH, van Schaik DJF, van Marwijk HWJ, van der Horst HE.
    PLoS One; 2018 Oct 01; 13(12):e0208570. PubMed ID: 30566441
    [Abstract] [Full Text] [Related]

  • 18. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM, Elders PJ, Boons CC, Bosmans JE, Nijpels G, Hugtenburg JG.
    Trials; 2017 Jan 19; 18(1):29. PubMed ID: 28103948
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness analysis of a multiple health behaviour change intervention in people aged between 45 and 75 years: a cluster randomized controlled trial in primary care (EIRA study).
    Aznar-Lou I, Zabaleta-Del-Olmo E, Casajuana-Closas M, Sánchez-Viñas A, Parody-Rúa E, Bolíbar B, Iracheta-Todó M, Bulilete O, López-Jiménez T, Pombo-Ramos H, Martín Miguel MV, Magallón-Botaya R, Maderuelo-Fernández JÁ, Motrico E, Bellón J, Martí-Lluch R, Rubio-Valera M, Serrano-Blanco A.
    Int J Behav Nutr Phys Act; 2021 Jul 02; 18(1):88. PubMed ID: 34215275
    [Abstract] [Full Text] [Related]

  • 20. The Cost-Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies.
    Bosmans JE, van der Laan DM, Yang Y, Elders PJM, Boons CCLM, Nijpels G, Hugtenburg JG.
    Front Pharmacol; 2019 Jul 02; 10():210. PubMed ID: 30899223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.